ONECUT2 is a targetable master regulator of aggressive variants of castration-resistant prostate

被引：0
|
作者：
Rotinen, Mirja [1 ]
You, Sungyong [1 ]
Yang, Julie [1 ]
Coetzee, Simon [1 ]
Huang, Wen-Chin [1 ]
Huang, Fangjin [1 ]
Pan, Xinlei [1 ]
Yanez, Alberto [1 ]
Hazelett, Dennis [1 ]
Chu, Chia-Yi [1 ]
Chung, Leland [1 ]
Freedland, Stephen [1 ]
Di Vizio, Dolores [1 ]
Garraway, Isla [2 ]
Murali, Ramachandran [1 ]
Knudsen, Beatrice [1 ]
Freeman, Michael [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 16期
关键词：
D O I：
10.1158/1538-7445.PRCA2017-A047
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A047
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [1] ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
    Rotinen, Mirja
    You, Sungyong
    Yang, Julie
    Coetzee, Simon G.
    Reis-Sobreiro, Mariana
    Huang, Wen-Chin
    Huang, Fangjin
    Pan, Xinlei
    Yanez, Alberto
    Hazelett, Dennis J.
    Chu, Chia-Yi
    Steadman, Kenneth
    Morrissey, Colm M.
    Nelson, Peter S.
    Corey, Eva
    Chung, Leland W. K.
    Freedland, Stephen J.
    Di Vizio, Dolores
    Garraway, Isla P.
    Murali, Ramachandran
    Knudsen, Beatrice S.
    Freeman, Michael R.
    NATURE MEDICINE, 2018, 24 (12) : 1887 - +
  • [2] ONECUT2 is a novel target for treatment of castration-resistant prostate cancer
    Joglekar, Tejashree
    Lin, Jianqing
    Shibata, Maho
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (02) : 89 - 90
  • [3] ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
    Mirja Rotinen
    Sungyong You
    Julie Yang
    Simon G. Coetzee
    Mariana Reis-Sobreiro
    Wen-Chin Huang
    Fangjin Huang
    Xinlei Pan
    Alberto Yáñez
    Dennis J. Hazelett
    Chia-Yi Chu
    Kenneth Steadman
    Colm M. Morrissey
    Peter S. Nelson
    Eva Corey
    Leland W. K. Chung
    Stephen J. Freedland
    Dolores Di Vizio
    Isla P. Garraway
    Ramachandran Murali
    Beatrice S. Knudsen
    Michael R. Freeman
    Nature Medicine, 2018, 24 : 1887 - 1898
  • [4] Activation of ONECUT2 by RB1 loss in castration-resistant prostate cancer
    Qian, Chen
    Yang, Qian
    Freedland, Stephen J.
    Di Vizio, Dolores
    Ellis, Leigh
    You, Sungyong
    Freeman, Michael R.
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2022, 10 (06): : 397 - 407
  • [5] Aggressive Variants of Castration-Resistant Prostate Cancer
    Beltran, Himisha
    Tomlins, Scott
    Aparicio, Ana
    Arora, Vivek
    Rickman, David
    Ayala, Gustavo
    Huang, Jiaoti
    True, Lawrence
    Gleave, Martin E.
    Soule, Howard
    Logothetis, Christopher
    Rubin, Mark A.
    CLINICAL CANCER RESEARCH, 2014, 20 (11) : 2846 - 2850
  • [6] ONECUT2: ATargetable Master Regulator of Progression to Neuroendocrine Differentiation from Prostate Adenocarcinoma
    Rotinen, Mirja
    You, Sungyong
    Yang, Julie
    Coetzee, Simon
    Huang, Wen-Chin
    Huang, Fangjin
    Pan, Xinlei
    Yanez, Alberto
    Hazelett, Dennis
    Chu, Chia-Yi
    Chung, Leland
    Di Vizio, Dolores
    Garraway, Isla
    Murali, Ramachandran
    Knudsen, Beatrice
    Freeman, Michael
    PANCREAS, 2018, 47 (03) : 353 - 354
  • [7] ONECUT2 as a key mediator of androgen receptor-independent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer
    Choi, WonSeok William
    Boland, Julia L.
    Lin, Jianqing
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 165 - 170
  • [8] Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
    Bigot, Ludovic
    Sabio, Jonathan
    Poiraudeau, Loic
    Annereau, Maxime
    Menssouri, Naoual
    Helissey, Carole
    Deas, Olivier
    Aglave, Marine
    Ibrahim, Tony
    Pobel, Cedric
    Nobre, Catline
    Nicotra, Claudio
    Ngo-Camus, Maud
    Lacroix, Ludovic
    Rouleau, Etienne
    Tselikas, Lambros
    Judde, Jean -Gabriel
    Chauchereau, Anne
    Bernard-Tessier, Alice
    Patrikidou, Anna
    Naoun, Natacha
    Flippot, Ronan
    Colomba, Emeline
    Fuerea, Alina
    Albiges, Laurence
    Lavaud, Pernelle
    Massard, Christophe
    Friboulet, Luc
    Fizazi, Karim
    Besse, Benjamin
    Scoazec, Jean-Yves
    Loriot, Yohann
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 527 - 536
  • [9] Novel preclinical models of aggressive variants of castration-resistant prostate cancer
    Bigot, Ludovic
    Sabio, Jonathan
    Ibrahim, Tony
    Menssouri, Naoual
    Poiraudeau, Loic
    Helissey, Carole
    Scoazec, Jean-Yves
    Merabet, Zahira
    De Baere, Thierry
    Deschamps, Frederic
    Ngocamus, Maud
    Nicotra, Claudio
    Rouleau, Etienne
    Lacroix, Ludovic
    Deas, Olivier
    Friboulet, Luc
    Vassal, Gilles
    Solary, Eric
    Soria, Jean-Charles
    Fizazi, Karim
    Andre, Fabrice
    Massard, Christophe
    Besse, Benjamin
    Loriot, Yohann
    CANCER RESEARCH, 2020, 80 (16)
  • [10] Emerging Variants of Castration-Resistant Prostate Cancer
    Vlachostergios, Panagiotis J.
    Puca, Loredana
    Beltran, Himisha
    CURRENT ONCOLOGY REPORTS, 2017, 19 (05)
12345